A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol

Neuropeptides

Volumn 43, Issue 3, 2009, Pages 251-257

  Umathe, S N ^a   Wanjari, M M ^b   Manna, S S S ^a   Jain, N S ^c  

^a RTM NAGPUR UNIVERSITY   (India)

^b Central Research Institute (Ayurveda)   (India)

^c JL Chaturvedi College of Pharmacy   (India)

Author keywords

Antide; Antipsychotics; Conditioned avoidance response; Leuprolide; Luteinizing hormone releasing hormone

Indexed keywords

GONADORELIN; HALOPERIDOL; ITURELIX; LEUPRORELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSION; AVOIDANCE BEHAVIOR; CATALEPSY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; MALE; NARCOLEPSY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; AVOIDANCE LEARNING; CATALEPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; GONADOTROPIN-RELEASING HORMONE; HALOPERIDOL; LEUPROLIDE; MALE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 67349190561     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2009.03.002     Document Type: Article

References (33)

1. Alexander J.L., Burger H., Dennerstein L., Woods N.F., Davis R.S., Kotz K., Winkle J.V., Richardson G., Ratka A., and Kessel B. Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric co-morbidity. Expert Rev. Neurotherapeutics 7 (2007) 115-137
2. Arnt J. Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol. Toxicol. (Copenh). 51 (1982) 321-329
3. Baldessarini R.J., Cohen B.M., and Teicher M.H. Significance of neuroleptic dose and plasma levels in pharmacological treatment of psychoses. Arch. Gen. Psychiatry 45 (1988) 75-91
4. Cooper B.R., Breese G.R., Grant L.D., and Howard L.L. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine. J. Pharmacol. Exp. Ther. 185 (1973) 358-370
5. Davidson A.B., and Weidley E. Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats. Life Science 18 (1976) 1279-1284
6. Erlik M.D., and Judd H. Estrogen levels in postmenopausal women with hot flashes. Obstet. Gynecol. 59 (1982) 403-407
7. Inoue A., Seto M., Sugita S., Hide I., Hirose T., Koga N., Kikuchi T., and Nakata Y. Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary. Mol. Brain Res. 55 (1998) 285-292
8. Jennes L., Dalati B., and Conn P.M. Distribution of gonadotropin-releasing hormone binding sites in the rat nervous system. Brain. Res. 452 (1988) 156-164
9. Kádár T., Telegdy G., and Schally A.V. Neuropharmacological actions of the superactive agonist analog D-Trp-6-LHRH after peripheral injection into mice. Neuropharmacology 17 (1990) 81-86
10. Kádár T., Telegdy G., and Schally A.V. Behavioral effects of centrally administered LHRH agonist in rats. Physiol. Behav. 51 (1992) 601-605
11. Kim W., Jessen H.M., Auger A.P., and Terasawa E. Postmenopausal increase in KiSS-1, GPR54, and luteinizing hormone releasing hormone (LHRH-1) mRNA in the basal hypothalamus of female rhesus monkeys. Peptides 30 (2009) 103-110
12. Lacau-Mengido I.M., Becú-Villalobos D., Thyssen S.M., Rey E.B., Lux-Lantos V.A., and Libertun C. Antidopaminergic-induced hypothalamic LHRH release and pituitary gonadotropin secretion in 12 day-old female and male rats. J. Neuroendocrinol. 2 (1993) 705-709
13. Leblanc P., Crumeyrolle M., Latouche J., Jordan D., Fillion G., L'Heritier A., Kordon C., Dussaillant M., Rostene W., and Haour F. Characterization and distribution of receptors for gonadotropin-releasing hormone in the rat hippocampus. Neuroendocrinology 48 (1988) 482-488
14. Mauk M.D., Olson G.A., Kastin A.J., and Olson R.D. Behavioral effects of LHRH. Neurosci. Biobehav. Rev. 4 (1980) 1-8
15. Merchenthaler I., Gorcs T., Sétáló G., Petrusz P., and Flerkó B. Gonadotropin releasing hormone and pathways in the rat brain. Cell Tissue Res. 237 (1984) 15-29
16. Mohan Kumar P.S., Mohan Kumar S.M., Arbogast L., Quadri S.K., and Voogt J.L. Effects of chronic hyperprolactinemia on tuberoinfundibular dopaminergic neurons. Proc. Soc. Exp. Biol. Med. 217 (1998) 461-465
17. Mora S., Afani A., Kusanovic R., Tapia C., and Díaz-Véliz G. Behavioral effects of intracerebral administration of luteinizing hormone releasing hormone (LHRH) in rats. Pharmacol. Biochem. Behav. 38 (1991) 705-709
18. Mora S., and Díaz-Véliz G. Influence of luteinizing hormone releasing hormone (LHRH) on the behavioral effects of amphetamine in rats. Pharmacol. Biochem. Behav. 19 (1983) 157-161
19. Mora S., and Díaz-Véliz G. Pharmacological evidence of catecholaminergic involvement in the behavioral effects of luteinizing hormone releasing hormone in rats. Pharmacol. Biochem. Behav. 24 (1986) 433-438
20. Mora S., and Díaz-Velíz G. Effects of pretreatment with luteinizing hormone releasing hormone (LHRH) on behaviors induced by apomorphine in rats. Pharmacol. Biochem. Behav. 31 (1988) 291-296
21. Mora S., Díaz-Véliz G., and Belmar J. Is LHRH a modulator of brain dopaminergic activity in the rat?. Arch. Biol. Med. Exp. (Santiago) 20 (1987) 161
22. Mora S., Dussaubat N., and Díaz-Véliz G. Effects of LHRH on avoidance conditioning in normally cycling and ovariectomized female rats. Pharmacol. Biochem. Behav. 61 (1998) 221-228
23. Mora S., Nasello A.G., Mandelli-Lopes M., and Díaz-Véliz G. LHRH and rat avoidance behavior: influence of castration and testosterone. Physiol. Behav. 30 (1983) 19-22
24. Moss R.L., and McCann S.M. Induction of mating behavior in rats by luteinizing hormone releasing factor. Science 181 (1973) 177-179
25. Nasello A.G., Bydlowski C.R., and Felicio L.F. The effect of LHRH on rat conditioned avoidance behavior: interaction with brain catecholamines. Pharmacol. Biochem. Behav. 37 (1990) 639-642
26. Reubi J.C., and Maurer R. Visualization of LHRH receptors in the rat brain. Eur. J. Pharmacol. 106 (1984) 453-454
27. Schlösser R., Schlegel S., Hiemke C., Nickel O., Bockisch A., Rao M.L., and Hahn K. [123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects. Psychiatry Res. 75 (1997) 103-114
28. Spitzer M., Sajjad R., and Benjamin F. Pattern of development of hyperprolactinemia after initiation of haloperidol therapy. Obstet. Gynecol. 91 (1998) 693-695
29. Tasaka K., Mivake A., Sakumoto T., and Aono T. Dopamine decreases release of luteinizing hormone releasing hormone from superfused rat mediobasal hypothalamus. J. Endocrinol. Invest. 8 (1985) 373-376
30. Ugale R.R., Hirani K., Morelli M., and Chopde C.T. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents. Neuropsychopharmacology 29 (2004) 1597-1609
31. Wang W.K., Jeng L.S., Chiang Y., and Chien N.K. Nature. Inhibition of dopamine biosynthesis by gonadotropin-releasing hormone in rat 296 (1982) 354
32. Yurek D.M., and Randall P.K. Simultaneous catalepsy and apomorphine-induced stereotypic behavior in mice. Life Science 37 (1985) 1665-1673
33. Zis A.P., Fibiger H.C., and Phillips A.G. Reversal by L-dopa of impaired learning due to destruction of the dopaminergic nigro-neo-striatal projection. Science 185 (1974) 960-962